Inhibition of exercise-induced bronchospasm by zileuton: A 5-lipoxygenase inhibitor

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 3, 1996, Pages 931-935

  Meltzer, Susan S ^b   Hasday, Jeffrey D ^b   Cohn, Judith ^b   Bleecker, Eugene R ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ZILEUTON;

ARTICLE; BRONCHODILATATION; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; EXERCISE INDUCED ASTHMA; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029937854     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.3.8630575     Document Type: Article

References (38)

1. McFadden, E. R., and R. H. Ingram. 1979. Exercise-induced asthma, observations on the initiating stimulus. N. Engl. J. Med. 301:763-769.
2. McFadden, E. R. 1987. Exercise and asthma. N. Engl. J. Med. 317: 502-504.
3. Gilbert, I. A., and E. R. McFadden. 1992. Airway cooling and rewarming, the second reaction sequence in exercise-induced asthma. J. Clin. Invest. 90:699-704.
4. Crimi, E., A. Balbo, M. Milanese, A. Miadonna, G. A. Rossi, and V. Brusasco. 1992. Airway inflammation and occurrence of delayed bronchoconstriction in exercise-induced asthma. Am. Rev. Respir. Dis. 146:507-512.
5. Broide, D. H., S. Eisman, J. W. Ramsdell, P. Ferguson, L. B. Schwartz, and S. I. Wasserman. 1990. Airway levels of mast-cell mediators in exercise-induced asthma. Am. Rev. Respir. Dis. 141:563-568.
6. Israel, E., R. Dermarkarian, M. Rosenber, R. Sperling, G. Taylor, R. Rubin, and J. M. Drazen. 1990. The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air. N. Engl. J. Med. 323: 1740-1744.
7. Venge, P., J. Henriksen, and R. Dahl. 1991. Eosinophils in exercise-induced asthma. J. Allergy Clin. Immunol. 88:699-704.
8. Bierman, C. W., S. G. Spiro, and I. Petheram. 1984. Characterization of the late response in exercise-induced asthma. J. Allergy Clin. Immunol. 74:701-706.
9. Rubinstein, I., H. Levison, A. S. Slutsky, H. Hak, J. Wells, N. Zamel, and A. S. Rebucik. 1987. Immediate and delayed bronchoconstriction after exercise in patients with asthma. N. Engl. J. Med. 317: 482-485.
10. Zawadski, D. K., K. A. Lenner, and E. R. McFadden. 1988. Re-examination of the late asthmatic response to exercise. Am. Rev. Respir. Dis. 137:837-841.
11. Zawadski, D. K., K. A. Lenner, and E. R. McFadden. 1988. Effect of exercise on nonspecific airway reactivity in asthmatics. J. Appl. Physiol. 64:812-816.
12. Jarjour, N. N., and W. J. Calhoun. 1992. Exercise-induced asthma is not associated with mast cell activation or airway inflammation. J. Allergy Clin. Immunol. 89:60-68.
13. Finnerty, J. P., and S. T. Holgate. 1992. The contribution of histamine release and vagal reflexes, alone and in combination, to exercise-induced asthma. Eur. Respir. J. 6:1132-1137.
14. Finnerty, J. P., and S. T. Holgate. 1990. Evidence for the roles of histamine and prostaglandins as mediators in exercise-induced asthma: the inhibitory effect of terfenadine and fluribofen alone and in combination. Eur. Respir. J. 3:540-547.
15. 4 after exercise challenge in children with asthma. J. Allergy Clin. Immunol. 89:1111-1119.
16. 4-receptor antagonist. N. Engl. J. Med. 323:1736-1739.
17. 4 receptor antagonist ICI 204,219 against exercise-induced asthma. Am. Rev. Respir. Dis. 147:1413-1418.
18. 4 receptor antagonist. Am. Rev. Respir. Dis. 145:746-749.
19. Kemp, J. P., R. J. Dockhorn, W. W. Busse, E. R. Bleecker, and A. van As. 1994. Prolonged effect of inhaled salmeterol against exercise-induced bronchospasm. Am. J. Respir. Crit. Care. Med. 150:1612-1615.
20. Walden, S. M., E. R. Bleecker, K. Chahal, E. J. Britt, P. Mason, and S. Permutt. 1984. Effect of alpha-adrenergic blockade on exercise-induced asthma and conditioned cold air. Am. Rev. Respir. Dis. 130:357-362.
21. Bleecker, E. R. 1984. Exercise-induced asthma, physiologic and clinical considerations. Clin. Chest Med. 5:100-119.
22. Israel, E., P. Rubin, J. P. Kemp, J. Grossman, W. Peirson, S. C. Siegel, D. Tinkelman, J. J. Murray, W. Busse, A. T. Segal, J. Fish, H. B. Kaiser, D. Ledford, S. Wenzel, R. Rosenthal, J. Coohn, C. Lanni, H. Pearlman, P. Karahalios, and J. M. Drazen. 1993. The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma. Ann. Intern. Med. 119:1059-1066.
23. Kumlin, M., M. Hamberg, E. Granstrom, T. Bjorck, B. Dahlen, H. Matsuda, O. Zetterstrom, and S. Dahlen. 1990. 15(S)-Hydroxyeicosatetraenoic acid is the major arachidonic acid metabolite in human bronchi: associated with airway epithelium. Archives of Biochemistry and Biophysics 282:254-262.
24. Kumlin, M., and S. E. Dahlen. 1990. Characteristics of formation and further metabolism of leukotrienes in the chopped human lung. Biochim. Biophys. Acta. 1044:201-210.
25. 4. Proc. Natl. Acad. Sci. U.S.A. 80:1712-1716.
26. 4 in-vitro. Am. Rev. Respir. Dis. 146:923-929.
27. Ellis, J. L., and B. J. Undeem. 1994. Role of cysteinyl-leukotrienes and histamine in mediating intrinsic tone in isolated human bronchi. Am. J. Respir. Crit. Care Med. 149:118-122.
28. 4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. Am. Rev. Respir. Dis. 142:112-119.
29. Smith, C. M., P. E. Christie, R. J. Hawksworth, F. Thien, and T. H. Lee. 1991. Urinary leukotriene E4 levels after allergen and exercise challenge in bronchial asthma. Am. Rev. Respir. Dis. 144:1411-1413.
30. 4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma. J. Allergy Clin. Immunol. 90:193-201.
31. Findlay, S. R., J. M. Barden, C. B. Easkey, and M. Glass. 1992. Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma. J. Allergy Clin. Immunol. 89:1040-1045.
32. Taylor, I. K., K. M. O'Shaughnessy, R. W. Fuller, and C. T. Dollery. 1991. Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet 337:690-694.
33. Dahlen, B., O. Zetterstrom, T. Bjorck, and S. E. Dahlen. 1994. The leukotriene antagonist ICI 204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics. Eur. Respir. J. 7:324-731.
34. Diamant, Z., M. C. Timmers, H. Van der Veen, B. S. Friedman, M. DeSmet, M. Depre, D. Hilliard, E. H. Bel, and P. J. Sterk. 1995. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo. J. Allergy Clin. Immunol. 95:42-51.
35. 4) excretion in exercise-induced bronchoconstriction (abstract). Am. Rev. Respir. Dis. 145:A15.
36. 4 by neutrophils stimulated by unopsonized zymosan and by calcium ionophore after exercise-induced asthma. Am. Rev. Respir. Dis. 138:47-53.
37. Hui, K. P., I. K. Taylor, G. W. Taylor, P. Rubin, J. Kesterson, N. C. Barnes, and P. J. Barnes. 1991. Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients. Thorax 46:184-189.
38. Robuschi, M., E. Riva, M. Fuccella, E. Vida, R. Barnabe, M. Rossi, G. Gambaro, S. Spagnotto, and S. Bianco. 1992. Prevention of exercise-induced bronchoconstriction by a new leukotriene antagonist (SK&F 104353), a double-blind study versus disodium cromoglycate and placebo. Am. Rev. Respir. Dis. 145:1285-1288.